Light Mode
$3.50 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.50, $0.10 below the day’s high of $3.60
-0.50 (-12.50%) / 6M
Momentum, market sentiment, and recent alerts
NORD reads n/a: the 12-month move is -22.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Nordicus Partners Corp. is a biotech company, which specializes in developing breakthrough therapeutics in diseases with unmet medical needs. It focuses on acquisition and development of drugs from innovative biotech companies in the Nordics. The company was founded on April 7, 1993 and is headquartered in Beverly Hills, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.